Nevro Corp (NYSE:NVRO)
| 44.65 BATS BZX Real-Time Price As of 2:07pm ET |  +0.82 / +1.87%Today’s Change | 39.41 Today|||52-Week Range 168.19 | -44.92% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $1.7B |
Company Description
Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
Contact Information
Nevro Corp. 1800 Bridge Parkway Redwood City California 94065 |
Employees
Shareholders
| Mutual fund holders | 63.95% |
| Other institutional | 38.90% |
| Individual stakeholders | 20.26% |
Top Executives
| D. Keith Grossman | Chairman, President & Chief Executive Officer |
| Roderick H. MacLeod | Chief Financial Officer |
| David Caraway | Chief Medical Officer |
| Christopher Christoforou | Vice President-Technical Operations |
| Stephen Smith | Vice President-Information Technology |
